Progressive multifocal leukoencephalopathy overview: Difference between revisions
No edit summary |
m (Changes made per Mahshid's request) |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
{{Progressive multifocal leukoencephalopathy}}{{CMG}} | __NOTOC__ | ||
{{Progressive multifocal leukoencephalopathy}} | |||
{{CMG}} | |||
==Overview== | ==Overview== | ||
'''Progressive multifocal leukoencephalopathy''' (PML), also known as progressive multifocal leukoencephalitis, is a rare and usually fatal [[virus|viral]] disease that is characterized by progressive damage (''-pathy'') or [[inflammation]] (''-itis'') of the [[white matter]] (''leuko-'') of the [[brain]] (''-encephalo-'') at multiple locations (''multifocal''). It occurs almost exclusively in people with severe [[immune deficiency]], e.g. transplant patients on [[immunosuppressive]] medications, or [[AIDS]] patients. | '''Progressive multifocal leukoencephalopathy''' (PML), also known as progressive multifocal leukoencephalitis, is a rare and usually fatal [[virus|viral]] disease that is characterized by progressive damage (''-pathy'') or [[inflammation]] (''-itis'') of the [[white matter]] (''leuko-'') of the [[brain]] (''-encephalo-'') at multiple locations (''multifocal''). It occurs almost exclusively in people with severe [[immune deficiency]], e.g. transplant patients on [[immunosuppressive]] medications, or [[AIDS]] patients. | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Psychiatry]] | [[Category:Psychiatry]] | ||
[[Category:Mental disorders due to a general medical condition]] | [[Category:Mental disorders due to a general medical condition]] | ||
[[Category:Neurology]] | [[Category:Neurology]] | ||
{{ | |||
{{ | {{WH}} | ||
{{WS}} | |||
Latest revision as of 18:48, 18 September 2017
|
Progressive multifocal leukoencephalopathy Microchapters |
|
Differentiating Progressive multifocal leukoencephalopathy from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Progressive multifocal leukoencephalopathy overview On the Web |
|
American Roentgen Ray Society Images of Progressive multifocal leukoencephalopathy overview |
|
Progressive multifocal leukoencephalopathy overview in the news |
|
Blogs on Progressive multifocal leukoencephalopathy overview |
|
Risk calculators and risk factors for Progressive multifocal leukoencephalopathy overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Progressive multifocal leukoencephalopathy (PML), also known as progressive multifocal leukoencephalitis, is a rare and usually fatal viral disease that is characterized by progressive damage (-pathy) or inflammation (-itis) of the white matter (leuko-) of the brain (-encephalo-) at multiple locations (multifocal). It occurs almost exclusively in people with severe immune deficiency, e.g. transplant patients on immunosuppressive medications, or AIDS patients.